Shypd.aiThe largest open index of AI toolsConvexia is an AI-driven platform that streamlines drug sourcing and evaluation. It uses an end-to-end AI stack to discover, evaluate, and accelerate overlooked drug assets, replacing manual diligence with fast execution.
Trending
About
Convexia offers an advanced AI platform designed to revolutionize drug sourcing and evaluation. It employs an end-to-end AI stack to identify and assess drug assets, significantly reducing the time and effort typically spent on manual diligence. The platform features an Asset Discovery Agent that scans globally for overlooked drug candidates, a Scientific Evaluation Stack with over 50 custom-tuned models for in silico simulations (binding, toxicity, ADME/PK), and a Market Insight Agent to rank assets based on market factors. Additionally, an Operational Risk Agent models execution risk, and a Probability of Success Model predicts likelihood of success. Human experts are integrated at multiple stages for review and validation, ensuring accuracy and trust in the AI-driven process. Convexia aims to accelerate the development of high-potential therapeutics by providing comprehensive insights from discovery to market.
Capabilities
Pricing & Plans
Paid · Enterprise
Not publicly disclosed. Check convexia.bio for current pricing.
FAQs
Trending
